Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobutada Tanaka

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Biotechnology for Biofuels|January 1, 2016
The impact of a single-nucleotide mutation of bgl2 on cellulase induction in a Trichoderma reesei mutantYosuke Shida, Kaori Yamaguchi, Mikiko Nitta, et al.
Scientific Reports|May 16, 2014
S46 peptidases are the first exopeptidases to be members of clan PAYasumitsu Sakamoto, Yoshiyuki Suzuki, Ippei Iizuka, et al.
Journal of Medicinal Chemistry|January 24, 2022
5-<i>C</i>-Branched Deoxynojirimycin: Strategy for Designing a 1-Deoxynojirimycin-Based Pharmacological Chaperone with a Nanomolar Affinity for Pompe DiseaseAtsushi Kato, Izumi Nakagome, Uta Kanekiyo, et al.
ACS Infectious Diseases|April 22, 2024
Reverse <i>N</i>-Substituted Hydroxamic Acid Derivatives of Fosmidomycin Target a Previously Unknown Subpocket of 1-Deoxy-d-xylulose 5-Phosphate Reductoisomerase (DXR)Mona A Abdullaziz, Sana Takada, Boris Illarionov, et al.
Journal of Medicinal Chemistry|May 6, 2026
Reverse Fosmidomycin Analogs as Bisubstrate Inhibitors: Binding Mode Elucidation and Mechanistic InsightsStefan Höfmann, Sana Takada, Boris Illarionov, et al.
Scientific Reports|September 21, 2019
Fragment-based discovery of the first nonpeptidyl inhibitor of an S46 family peptidaseYasumitsu Sakamoto, Yoshiyuki Suzuki, Akihiro Nakamura, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Biotechnology for Biofuels|January 1, 2016
The impact of a single-nucleotide mutation of bgl2 on cellulase induction in a Trichoderma reesei mutantYosuke Shida, Kaori Yamaguchi, Mikiko Nitta, et al.
Scientific Reports|May 16, 2014
S46 peptidases are the first exopeptidases to be members of clan PAYasumitsu Sakamoto, Yoshiyuki Suzuki, Ippei Iizuka, et al.
Journal of Medicinal Chemistry|January 24, 2022
5-<i>C</i>-Branched Deoxynojirimycin: Strategy for Designing a 1-Deoxynojirimycin-Based Pharmacological Chaperone with a Nanomolar Affinity for Pompe DiseaseAtsushi Kato, Izumi Nakagome, Uta Kanekiyo, et al.
ACS Infectious Diseases|April 22, 2024
Reverse <i>N</i>-Substituted Hydroxamic Acid Derivatives of Fosmidomycin Target a Previously Unknown Subpocket of 1-Deoxy-d-xylulose 5-Phosphate Reductoisomerase (DXR)Mona A Abdullaziz, Sana Takada, Boris Illarionov, et al.
Journal of Medicinal Chemistry|May 6, 2026
Reverse Fosmidomycin Analogs as Bisubstrate Inhibitors: Binding Mode Elucidation and Mechanistic InsightsStefan Höfmann, Sana Takada, Boris Illarionov, et al.
Scientific Reports|September 21, 2019
Fragment-based discovery of the first nonpeptidyl inhibitor of an S46 family peptidaseYasumitsu Sakamoto, Yoshiyuki Suzuki, Akihiro Nakamura, et al.
Pageof 7